Acta diabetologia latina

, Volume 24, Issue 2, pp 171–172 | Cite as

Aspirin and non-enzymatic glycation

  • Antonio Ceriello
  • Dario Giugliano
  • Antonio Quatraro
  • Aldo Stante
Letter to the Editor
  • 19 Downloads

Keywords

Aspirin Cataract Antithrombin Nonenzymatic Glycation Nonenzymatic Glycosylation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Brownlee M., Vlassara H., Cerami A.: Inhibition of heparin-catalyzed human antithrombin III activity. by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes. —Diabetes33, 532, 1984.PubMedCrossRefGoogle Scholar
  2. 2.
    Ceriello A., Dello Russo P., Zuccotti C., Rosato G. B.: Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation. A preliminary report—Thrombos. Haemostas.52, 633, 1983Google Scholar
  3. 3.
    Ceriello A., Dello Russo P., Curcio F., Giugliano D.: Nonenzymatic glycosylation reduces antithrombin III activity—Thrombos. Haemostas.54, 363, 1984.Google Scholar
  4. 4.
    Ceriello A., Giugliano D., Dello Russo P., Tirelli A., Passariello N., Sgambato S.: Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes. A possible role for non-enzymatic glycosylation—Diabetes Care9, 32, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Ceriello A., Giugliano D., Quatraro A., Consoli G., Stante A., Dello Russo P., D'Onofrio F.: Daily rapid blood glucose variations may condition antithrombin III biological activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile nonenzymatic glycation—Diabète et Métabol.13, 16, 1987.Google Scholar
  6. 6.
    Ceriello A., Giugliano D., Quatraro A., Consoli G., Stante A., Dello Russo P., D'Onofrio F.: Induced-hyperglycemia alters antithrombin III activity in healthy normal subjects. —Diabetes36, 320, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Ceriello A., Giugliano D., Quatraro A., Consoli G., Stante A., Dello Russo P., D'Onofrio F.: Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics—Haemostasis16, 458, 1986.PubMedGoogle Scholar
  8. 8.
    Giuglano D., Torella R., Siniscalchi N., Improta L., D'Onofrio F.: The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man—Diabetologia14, 359, 1978.CrossRefGoogle Scholar
  9. 9.
    van Heyningen R., Harding J. J.: Do aspirin analgesic protect against cataract?—Lanceti, 1111, 1986.CrossRefGoogle Scholar
  10. 10.
    van Heyningen R., Harding J. J.: Aspirin-like analgesics and cataract—Lancetii, 23, 1986.Google Scholar
  11. 11.
    Williams A.: Aspirin, nifedipine and cataract—Lancetii, 42, 1986Google Scholar

Copyright information

© Casa Editrice «il Ponte» 1987

Authors and Affiliations

  • Antonio Ceriello
    • 1
  • Dario Giugliano
    • 1
  • Antonio Quatraro
    • 2
  • Aldo Stante
    • 2
  1. 1.Istituto di Clinica Medica I I Facoltà di MedicinaUniversità di NapoliNapoli
  2. 2.Laboratorio AnalisiCentro di DiabetologiaTarantoItaly

Personalised recommendations